UnitedHealth Group announced Dr. Scott Gottlieb, former U.S. Food and Drug Administration (FDA) commissioner, is joining its Board of Directors as an independent director, effective November 18, 2025. Dr. Gottlieb, 53, served as FDA commissioner from 2017 to 2019, where he became known for promoting transparency, strengthening patient safety and widening consumer choice. He led initiatives to modernize regulations to help foster medical innovation, promote competition in the pharmaceutical market, confront the opioid epidemic and curb youth tobacco use.
In addition to his FDA service, Dr. Gottlieb has held roles at the Centers for Medicare & Medicaid Services and on the Federal Health Information Technology Policy Committee. A practicing physician, he is an elected member of the National Academy of Medicine and serves as a senior fellow at the American Enterprise Institute and a partner at New Enterprise Associates. He also contributes to CNBC and CBS News.
Dr. Gottlieb also serves as a director of Pfizer Inc., Tempus AI Inc. and Illumina Inc.
